scorecardresearch
Clear all
Search

COMPANIES

No Data Found

NEWS

No Data Found
Sign in Subscribe
Stocks in focus: Bajaj Finance, ONGC, Vedanta, TCS and more

Stocks in focus: Bajaj Finance, ONGC, Vedanta, TCS and more

Stocks to watch out for today: Bajaj Finance, Vedanta, ONGC, TCS, Vedanta, Gland Pharma and more

Stocks in news: Bajaj Finance, ONGC, Vedanta, TCS and more Stocks in news: Bajaj Finance, ONGC, Vedanta, TCS and more
SUMMARY
  • Rategain Travel Technologies has announced a qualified institutions placement (QIP) to raise funds.
  • Tata Consultancy Services (TCS) has fixed the record date for its Rs 17,000 crore share buyback plan on November 25.

The domestic equity market closed higher on Wednesday. Sensex rose 742 points to end the session at 65,675 and Nifty gained 232 points to settle at 19,675.

Here's a look at stocks that are likely to remain in news today.

Bajaj Finance

The Reserve Bank of India (RBI) has directed Bajaj Finance to stop disbursing loans through two of its lending products - 'eCOM' and 'Insta EMI Card' - with immediate effect, as per an official statement issued on November 15.

Vedanta

Vedanta Group said the company's subsidiary, Malco Energy Limited, has set up a new unit in Saudi Arabia for copper business for SAR (saudi riyal) 1,00,000. The newly incorporated unit has been named 'Vedanta Copper International VCI Company Limited', according to an exchange filing by the company.

ONGC

Top oil and gas producer ONGC plans to invest about Rs 1 lakh crore in setting up two petrochemical plants to convert crude oil directly into high-value chemical products as it prepares for energy transition, top company officials said.

Rategain Travel Technologies

Rategain Travel Technologies has announced a qualified institutions placement (QIP) to raise funds. The floor price for the issue has been fixed at Rs 676.66 per share.

Gland Pharma

Indian generic injectable-focused pharmaceutical company Gland Pharma said it has received tentative approval from the United States Food and Drug Administration (USFDA) for Angiotensin II Injection, 2.5 mg/mL Single Dose Vial.

TCS

IT major Tata Consultancy Services (TCS) has fixed the record date for its Rs 17,000 crore share buyback plan on November 25, the company said in its stock exchange filing on Wednesday. The company announced its share buyback plan at a price of Rs 4,150 per share via tender offer on October 11.

Also read: Stock recommendations for November 16, 2023: TCS, Reliance Industries and Asian Paints

Disclaimer: Business Today provides stock market news for informational purposes only and should not be construed as investment advice. Readers are encouraged to consult with a qualified financial advisor before making any investment decisions.
Published on: Nov 16, 2023, 7:26 AM IST
×
Advertisement
Check Stock Price
Bajaj Finance Ltd
Bajaj Finance Ltd